최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Scientific reports, v.10 no.1, 2020년, pp.16316 -
Lee, Sang R. (College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Suite 401Veterinary medicine Bldg., Yuseong, Daejeon, 34134 Republic of Korea) , Choi, Woo-Young (College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Suite 401Veterinary medicine Bldg., Yuseong, Daejeon, 34134 Republic of Korea) , Heo, Jun H. (College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Suite 401Veterinary medicine Bldg., Yuseong, Daejeon, 34134 Republic of Korea) , Huh, Jiyoung (College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Suite 401Veterinary medicine Bldg., Yuseong, Daejeon, 34134 Republic of Korea) , Kim, Globinna (Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505 Republic of Korea) , Lee, Kyu-Pil (College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Suite 401Veterinary medicine Bldg., Yuseong, Daejeon, 34134 Republic of Korea) , Kwun, Hyo-Jung (College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Suite 401Vete) , Shin, Hyun-Jin , Baek, In-Jeoung , Hong, Eui-Ju
Hepatic gluconeogenesis is the main pathway for blood glucose maintenance activated during fasting. Retardation of insulin action, such as in diabetes mellitus, activates gluconeogenesis during the fed state. While the role of progesterone (P4) in diabetes is controversial, the P4 receptor, progeste...
2. Edgerton DS Insulin’s direct effects on the liver dominate the control of hepatic glucose production J. Clin. Invest. 2006 116 521 527 10.1172/JCI27073 16453026
3. Exton JH Park CR Control of gluconeogenesis in liver. I. General features of gluconeogenesis in the perfused livers of rats J. Biol. Chem. 1967 242 2622 2636 6027238
4. Rodgers RL Glucagon and cyclic AMP: time to turn the page? Curr. Diabetes Rev. 2012 8 362 381 10.2174/157339912802083540 22587514
5. Quinn PG Yeagley D Insulin regulation of PEPCK gene expression: a model for rapid and reversible modulation Curr. Drug Targets Immune Endocr. Metabol. Disord. 2005 5 423 437 10.2174/156800805774912962 16375695
6. Spencer TE Bazer FW Biology of progesterone action during pregnancy recognition and maintenance of pregnancy Front. Biosci. 2002 7 d1879 1898 10.2741/spencer 12161340
7. Masuyama H Hiramatsu Y Potential role of estradiol and progesterone in insulin resistance through constitutive androstane receptor J. Mol. Endocrinol. 2011 47 229 239 10.1530/JME-11-0046 21768169
8. Costrini NV Kalkhoff RK Relative effects of pregnancy, estradiol, and progesterone on plasma insulin and pancreatic islet insulin secretion J. Clin. Invest. 1971 50 992 999 10.1172/JCI106593 4928265
9. Ashby JP Shirling D Baird JD Effect of progesterone on insulin secretion in the rat J. Endocrinol. 1978 76 479 486 10.1677/joe.0.0760479 204724
10. Oda S Nakajima M Toyoda Y Fukami T Yokoi T Progesterone receptor membrane component 1 modulates human cytochrome p450 activities in an isoform-dependent manner Drug Metab. Dispos. 2011 39 2057 2065 10.1124/dmd.111.040907 21825115
11. Rohe HJ Ahmed IS Twist KE Craven RJ PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding Pharmacol. Ther. 2009 121 14 19 10.1016/j.pharmthera.2008.09.006 18992768
12. Lee SR Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis Sci. Rep. 2018 8 15711 10.1038/s41598-018-34148-6 30356113
13. Meloni AR DeYoung MB Lowe C Parkes DG GLP-1 receptor activated insulin secretion from pancreatic beta-cells: mechanism and glucose dependence Diabetes Obes. Metab. 2013 15 15 27 10.1111/j.1463-1326.2012.01663.x 22776039
14. Zhang M Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic beta cells Mol. Cell Proteom. 2014 13 3049 3062 10.1074/mcp.M114.040196
15. Branisteanu DD Mathieu C Progesterone in gestational diabetes mellitus: guilty or not guilty? Trends Endocrinol. Metab. 2003 14 54 56 10.1016/S1043-2760(03)00003-1 12591170
16. Picard F Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta -cell proliferation Proc. Natl. Acad. Sci. U. S. A. 2002 99 15644 15648 10.1073/pnas.202612199 12438645
17. Peluso JJ Progesterone receptor membrane component 1 and its role in ovarian follicle growth Front. Neurosci. 2013 7 99 10.3389/fnins.2013.00099 23781168
18. Moncany ML Plas C Interaction of glucagon and epinephrine in the regulation of adenosine 3',5'-monophosphate-dependent glycogenolysis in the cultured fetal hepatocyte Endocrinology 1980 107 1667 1675 10.1210/endo-107-6-1667 6253273
19. Herzig S CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 Nature 2001 413 179 183 10.1038/35093131 11557984
20. Erion DM Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein Cell Metab. 2009 10 499 506 10.1016/j.cmet.2009.10.007 19945407
21. Karicheti V Langdale CL Ukai M Thor KB Characterization of a spinal, urine storage reflex, inhibitory center and its regulation by 5-HT1A receptors in female cats Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010 298 R1198 1208 10.1152/ajpregu.00599.2009 20164207
22. Will EA Liu X Peluso JJ AG 205, a progesterone receptor membrane component 1 antagonist, ablates progesterone’s ability to block oxidative stress-induced apoptosis of human granulosa/luteal cellsdagger Biol. Reprod. 2017 96 843 854 10.1093/biolre/iox013 28371915
23. Peluso JJ Liu X Gawkowska A Lodde V Wu CA Progesterone inhibits apoptosis in part by PGRMC1-regulated gene expression Mol. Cell Endocrinol. 2010 320 153 161 10.1016/j.mce.2010.02.005 20144686
24. How HY Sibai BM Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety Ther. Clin. Risk Manag. 2009 5 55 64 19436604
25. Cnattingius S Maternal obesity and risk of preterm delivery JAMA 2013 309 2362 2370 10.1001/jama.2013.6295 23757084
26. Rebarber A Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery Diabetes Care 2007 30 2277 2280 10.2337/dc07-0564 17563346
28. Basu R Chandramouli V Dicke B Landau B Rizza R Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis Diabetes 2005 54 1942 1948 10.2337/diabetes.54.7.1942 15983193
29. Menge BA Loss of inverse relationship between pulsatile insulin and glucagon secretion in patients with type 2 diabetes Diabetes 2011 60 2160 2168 10.2337/db11-0251 21677283
30. Hong EJ Levasseur MP Dufour CR Perry MC Giguere V Loss of estrogen-related receptor alpha promotes hepatocarcinogenesis development via metabolic and inflammatory disturbances Proc. Natl. Acad. Sci. U. S. A. 2013 110 17975 17980 10.1073/pnas.1315319110 24127579
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.